EPISODE · Sep 12, 2025 · 1H 8M
17 – GLP-1 in Type 1 Diabetes: beyond weight loss, towards metabolic therapy?
from The Glucose Never Lies® Podcast · host John Pemberton
Suggest guests or get in contactEpisode 17 — GLP-1 in Type 1 Diabetes: Beyond Weight Loss, Towards Metabolic Therapy Go to the Podcast page for all the notes, insights, and further reading & listening.Subscribe to The Glucose Never Lies® and receive the Summary PDF with all the key take-home messages and practical implementation strategies. Support The Glucose Never Lies® Podcast☕ Buy Me a Coffee💙 DonateGuest: Professor Viral Shah, MDProfessor of Medicine & Director of Diabetes Clinical Research, Center for Diabetes and Metabolic Diseases, IU School of MedicineAuthor of multiple clinical trials and consensus guidelines on GLP-1 and incretin therapies in type 1 diabetesIn this episode, John Pemberton speaks with Professor Viral Shah, a leading researcher in incretin therapies, about:The unique challenges of type 1 diabetes (insulin resistance, glucagon, weight gain).The evidence for GLP-1s in T1D: up to 30% insulin reduction, weight loss, and improved time in range.Practical guidance for people with type 1 and healthcare professionals: insulin titration, MDI vs pump vs AID, nutrition, and risk–benefit.Subscribe to The Glucose Never Lies® and receive the Summary PDF with all the key take-home messages and practical implementation strategies. Go to the Podcast page for all the notes, insights, and further reading & listening.Related GNL ResourcesOvercoming Insulin Resistance in T1DEight Causes of Insulin ResistanceSeven Ways to Combat Insulin ResistanceAutomated Insulin Delivery SeriesCGM SeriesGNL Podcast Episode 14 Overcoming Insulin ResistanceSupport GNL: https://buy.stripe.com/9B63cx4UO3KEdKC0Sp7Re00The Glucose Never Lies® is a registered trademark of The GNL Ltd. Company No. 16733595. UK VAT No. GB 516 3272 08.DisclaimerThis podcast is for education and informational purposes only. It does not constitute medical advice and is not a substitute for individualised care.The Glucose Never Lies® is independent by designWe do not accept sponsorships and advertising. We operate via education grants and donations from listeners who value independence. So, consider:Buying the GNL a Coffee:https://www.buymeacoffee.com/jspfree2EnquiriesCollaboration: John Pemberton — [email protected]: Anjanee Kohli — [email protected] The Glucose Never Lies®Website: https://theglucoseneverlies.com/Instagram: https://www.instagram.com/theglucoseneverliesLinkedIn: https://www.linkedin.com/company/theglucoseneverliesLinkedIn: John Pemberton: https://www.linkedin.com/in/john-pemberton-587104361/X: https://twitter.com/GlucoseNLiesDisclaimer This content is for informational purposes only and does not constitute medical advice.© The Glucose Never Lies Ltd. All rights reserved.
What this episode covers
Suggest guests or get in contact Episode 17 — GLP-1 in Type 1 Diabetes: Beyond Weight Loss, Towards Metabolic Therapy Go to the Podcast page for all the notes, insights, and further reading & listening. Subscribe to The Glucose Never Lies® and receive the Summary PDF with all the key take-home messages and practical implementation strategies. Support The Glucose Never Lies® Podcast ☕ Buy Me a Coffee 💙 Donate Guest: Professor Viral Shah, MD Professor of Medicine & Directo...
NOW PLAYING
17 – GLP-1 in Type 1 Diabetes: beyond weight loss, towards metabolic therapy?
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m